Zywie LLC, based in Monmouth Junction, NJ, is a therapeutics company specializing in the treatment of metabolic and neurodegenerative disorders, specifically Lysosomal Storage Diseases (LSDs). Their innovative approach involves the use of pharmacological chaperones to correct protein misfolding and improve protein trafficking within cells.
With a strong focus on intellectual property, Zywie holds a portfolio of use patents licensed from The Hospital for Sick Children in Toronto, as well as patents on deuterated and halogenated forms of Ambroxol. Their research aims to address the multi-billion dollar market of LSD treatments through cutting-edge drug development strategies.
Generated from the website